PGP and neoplasm: As would be predicted from the cell culture data, the anti-tumor activity of EC1456 was similar to that of vintafolide in the low P-gp expressing KB-CR2000 model, but EC1456 was found to be far superior to vintafolide against the higher P-gp expressing KB-PR10 tumor model.